BIO-key (BKYI) announced that it received a notification letter from Nasdaq informing the company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission, due to the company’s failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2024. The notification letter has no immediate effect on the listing or trading of the company’s common stock on the Nasdaq Capital Market.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BKYI:
- BIO-key International Delays Annual Report Filing
- BIO-key partners with Arrow ECS Iberia for Channel Alliance Partner program
- BIO-key International Reports Reduced Losses Amid Strategic Shift
- Bio-Key’s Strategic Shift Boosts Margins Amid Revenue Challenges
- BIO-key reports Q4 EPS (53c) vs. ($3.99) last year